Stern Lawrence D 4
4 · Talecris Biotherapeutics Holdings Corp. · Filed Apr 1, 2010
Insider Transaction Report
Form 4
Stern Lawrence D
DirectorChairman & CEO
Transactions
- Tax Payment
Common Stock
2010-03-31$19.92/sh−127,448$2,538,764→ 1,202,102 total
Footnotes (1)
- [F1]The number of shares reported includes includes 186,600 shares that have not yet vested of the Issuer's common stock that were granted by the Issuer to the Reporting Person on July 25, 2007 and which will vest on March 31, 2011, subject to the Reporting Person remaining employed by the Issuer through that date, as detailed in a restricted stock award agreement by and between the Issuer and the Reporting Person, dated as of July 25, 2007. Also includes restricted share units representing the right to receive 45,366 shares of the Issuer's common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.